Related Experiment Video
Updated: May 20, 2025

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Diabetes can impact cellular immunity in solid tumors.
Malgorzata A Garstka1, Lukasz Kedzierski2, Tomasz Maj3
1Department of Endocrinology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710016, China; Core Research Laboratory, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710016, China.
Type 2 diabetes (T2D) may worsen cancer immunosuppression, impacting antitumor immunity. This review explores how T2D affects solid tumors, potentially through myeloid and lymphoid cell dysfunction.
Area of Science:
- Immunology
- Oncology
- Metabolic Disorders
Background:
- Cancer and type 2 diabetes (T2D) are globally prevalent, often co-occurring conditions.
- The immune system is crucial for tumor elimination, influenced by metabolic factors like glucose.
- Diabetes dysregulates immune responses, while cancer establishes an immunosuppressive tumor microenvironment.
Purpose of the Study:
- To review the interplay between T2D and solid tumors.
- To examine how T2D might exacerbate cancer-induced immunosuppression.
- To identify challenges and potential mechanisms in this interaction.
Main Methods:
- Literature review of existing research on T2D and cancer immunity.
- Analysis of data from both preclinical (mouse models) and clinical (human tissues) studies.
- Exploration of proposed immunological mechanisms.
Main Results:
- Evidence suggests T2D can negatively impact antitumor immune responses.
- Inconsistencies exist between mouse models and human data.
- Potential mechanisms involve myeloid cell-driven immunosuppression and impaired antigen presentation.
- Lymphoid cell exhaustion is another implicated factor.
Conclusions:
- T2D may exacerbate the immunosuppressive tumor microenvironment.
- Understanding this interplay is critical for developing effective cancer therapies in diabetic patients.
- Further research is needed to clarify mechanisms and resolve data inconsistencies.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Tumor Immunotherapy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

